IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $331,000 | -63.9% | 29,996 | -45.5% | 0.01% | -52.4% |
| Q1 2022 | $916,000 | -31.3% | 55,000 | -21.3% | 0.02% | -30.0% |
| Q4 2021 | $1,334,000 | -27.9% | 69,861 | -6.9% | 0.03% | -25.0% |
| Q3 2021 | $1,850,000 | +7.8% | 75,000 | +13.7% | 0.04% | +5.3% |
| Q2 2021 | $1,716,000 | +74.6% | 65,935 | +112.3% | 0.04% | +72.7% |
| Q1 2021 | $983,000 | +10.8% | 31,061 | +62.4% | 0.02% | +29.4% |
| Q4 2020 | $887,000 | -33.6% | 19,125 | -52.8% | 0.02% | -52.8% |
| Q3 2020 | $1,335,000 | +24.4% | 40,551 | +3.7% | 0.04% | +16.1% |
| Q2 2020 | $1,073,000 | +23.6% | 39,086 | +34.8% | 0.03% | -8.8% |
| Q1 2020 | $868,000 | +1.2% | 29,000 | -6.5% | 0.03% | +142.9% |
| Q4 2019 | $858,000 | +141.7% | 31,000 | +59.0% | 0.01% | +100.0% |
| Q3 2019 | $355,000 | – | 19,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |